- Home
- RVNC vs MPLN Comparison
RVNC vs MPLN Comparison
Compare RVNC & MPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- MPLN
- Stock Information
- Founded
- RVNC 1999
- MPLN 1980
- Country
- RVNC United States
- MPLN United States
- Employees
- RVNC N/A
- MPLN N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- MPLN Business Services
- Sector
- RVNC Health Care
- MPLN Consumer Discretionary
- Exchange
- RVNC Nasdaq
- MPLN Nasdaq
- Market Cap
- RVNC 546.4M
- MPLN 188.6M
- IPO Year
- RVNC 2014
- MPLN N/A
- Fundamental
- Price
- RVNC $5.29
- MPLN $10.89
- Analyst Decision
- RVNC Buy
- MPLN Hold
- Analyst Count
- RVNC 10
- MPLN 2
- Target Price
- RVNC $10.86
- MPLN $25.00
- AVG Volume (30 Days)
- RVNC 1.3M
- MPLN 75.1K
- Earning Date
- RVNC 11-06-2024
- MPLN 11-05-2024
- Dividend Yield
- RVNC N/A
- MPLN N/A
- EPS Growth
- RVNC N/A
- MPLN N/A
- EPS
- RVNC N/A
- MPLN N/A
- Revenue
- RVNC $251,178,000.00
- MPLN $954,923,000.00
- Revenue This Year
- RVNC $20.36
- MPLN N/A
- Revenue Next Year
- RVNC $31.66
- MPLN $0.63
- P/E Ratio
- RVNC N/A
- MPLN N/A
- Revenue Growth
- RVNC 40.23
- MPLN N/A
- 52 Week Low
- RVNC $2.30
- MPLN $6.35
- 52 Week High
- RVNC $9.75
- MPLN $69.20
- Technical
- Relative Strength Index (RSI)
- RVNC 44.50
- MPLN 55.66
- Support Level
- RVNC $5.10
- MPLN $9.90
- Resistance Level
- RVNC $5.43
- MPLN $12.40
- Average True Range (ATR)
- RVNC 0.17
- MPLN 1.06
- MACD
- RVNC 0.02
- MPLN 0.26
- Stochastic Oscillator
- RVNC 66.67
- MPLN 69.14
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About MPLN MultiPlan Corporation
MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.